Thrombophilia, a blood clotting disorder, threatening especially pregnant women will be diagnosed and treated or free with subsidies from the state budget
The first genetic test center for hematologic disorders will be set up at the University Hospital in Bucharest. The money for this investment was obtained through a financing program offered by the Government of Norway.
Thrombophilia affects one in five people, according to studies. The disease may be hereditary or acquired during life and endangers especially pregnant women.
Currently, the tests that can detect if a pregnant woman is suffering from thrombophilia are conducted only in private clinics. A complete package, including blood coagulation tests and genetic testing amounts on average to 1,500 -2,000 lei. The next year these tests will be done for free at University Hospital in Bucharest .
The investment for the research and genetic testing laboratory for blood disorders and blood-cancer amounts to two million. The money was obtained with the help of the Ministry for European Funds through a financing program offered by the Norwegian government. Journalist Oana Stancu is a supporter of the project. Earlier this year, she gave birth to a baby girl, although suffering from thrombophilia.
The project has already obtained financing and pregnant women at risk for such a disease will begin to be tested by mid next year.